Can trifocal lens implants keep night driving safe and clear?

NCT ID NCT07755189

Not yet recruiting Knowledge-focused Sponsor: Jin Yang Source: ClinicalTrials.gov ↗

First seen Aug 10, 2026 · Last updated Aug 11, 2026 · Updated 1 time

Summary

This study follows adults having cataract surgery who choose either a trifocal or monofocal intraocular lens implant. It asks whether one type leads to more difficulty or visual disturbances, like glare or halos, when driving at night. Participants must be licensed drivers with regular night-driving habits. The main measure is a questionnaire about night-driving difficulty three months after surgery, with additional tests of vision and glare adaptation.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Trifocal intraocular lens (AcrySof IQ PanOptix TFNT00) or monofocal intraocular lens (Alcon)
What this could lead to
If trifocal lenses prove as safe for night driving as monofocal ones, more cataract patients could choose them without worrying about glare or halos.
What could go wrong
This is an observational study, not a randomized trial, so results may be influenced by patient choice. Also, outcomes rely on self-reported questionnaires, which can be subjective.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CATARACT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Eye and ENT hospital of Fudan University

    Shanghai, Shanghai Municipality, 200000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.